Mandate

VINGE ADVISES FIDELIO CAPITAL IN CONNECTION WITH NORDIC CAPITAL’S INVEStMENT IN ANICURA

July 01, 2014

Vinge advises Fidelio Capital in connection with Nordic Capital’s investment in AniCura. AniCura is owned by a large number of staff, the Foundation Djursjukhus i Stor-Stockholm and the Swedish investment firm Fidelio Capital. All parties will remain significant co-owners together with Nordic Capital. Through Nordic Capital’s co-ownership, resources will be made available for, among other things, establishing a new veterinary specialist neurological centre at AniCura Albano Animal Hospital in Danderyd, Sweden. Nordic Capital’s investment is subject to approval from the relevant competition authorities.

Partners Jonas Bergström and Johan Winnerblad together with, among others, associates Peter Sundgren, Gustav Jönsson, Amanda Winberg, Johan Mattson, Emelie Klefbeck and project assistant Pernilla Warg advises Fidelio Capital. Partner Marcus Glader advises on competition law.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026